Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00203541 · ClinicalTrials.gov registry record · NA
Effects of a New Antimicrobial Dressing on Wound Healing and Incidence of Sternal Wound Infections
A NA study, sponsored by Tyco Healthcare Group.
- Terminated
- Registry status
- NA
- Development phase
- 1,100
- Enrollment target
NCT00203541 is a NA study that was terminated before completion, run by Tyco Healthcare Group. The registered enrollment target is 1,100 participants.
The verdict
NCT00203541, a NA study, was terminated before completion, sponsored by Tyco Healthcare Group.
- TERMINATED
- Registry status
- NA
- Development phase
- 1,100 participants
- Enrollment target
Study Summary
The primary objective of this pivotal study is to determine if a new antimicrobial dressing, applied to the sternal incisions of cardiac surgical subjects, will demonstrate a decreased cumulative incidence rate(CI) of localized, superficial infections at the sternal incisional site as compared to the control group, regular, non-antimicrobial dressing.
Interventions
- DEVICE TELFA™ A.M.D. Island dressing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,100 participants |
| Start Date | 2004-02 |
| Est. Completion | 2006-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00203541
The ClinicalTrials.gov registry entry for NCT00203541 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1,100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tyco Healthcare Group, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TELFA™ A.M.D. Island dressing is the first listed.
NCT00203541 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00203541 about?
NCT00203541 is a clinical study titled "Effects of a New Antimicrobial Dressing on Wound Healing and Incidence of Sternal Wound Infections". The primary objective of this pivotal study is to determine if a new antimicrobial dressing, applied to the sternal incisions of cardiac surgical subjects, will demonstrate a decreased cumulative incidence rate(CI) of localized, superficial infections at the sternal incisional site as compared to th...
What is the current status of trial NCT00203541?
This trial is currently terminated. It is a NA study. The enrollment target is 1,100 participants. The study started on 2004-02. Estimated completion is 2006-06.
What interventions are being tested in trial NCT00203541?
The interventions under investigation include: TELFA™ A.M.D. Island dressing (DEVICE).
Who is sponsoring clinical trial NCT00203541?
This trial is sponsored by Tyco Healthcare Group, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.